Tempus AI
Tempus is a leader in AI-enabled precision medicine, dedicated to transforming healthcare by accelerating discovery, predicting treatment effectiveness, identifying clinical trials, and diagnosing diseases earlier through innovative technology and scientific research. They collaborate with healthcare providers, life sciences companies, and patients to improve patient outcomes and advance personalized care.
Industries
Nr. of Employees
Very Large (1000+)
Tempus AI
Patents
Artificial intelligence engine for directed hypothesis generation and ranking
US-12271832-B2
View DetailsPredicting total nucleic acid yield and dissection boundaries for histology slides
US-12165236-B2
View DetailsSystems and methods for interrogating clinical documents for characteristic data
US-12165753-B2
View Details
Artificial intelligence engine for directed hypothesis generation and ranking
US-12271832-B2
View DetailsPredicting total nucleic acid yield and dissection boundaries for histology slides
US-12165236-B2
View DetailsSystems and methods for interrogating clinical documents for characteristic data
US-12165753-B2
View DetailsProducts
Generative AI clinical assistant (EHR‑integrated)
A generative AI assistant that queries EHR data and institutional records to provide patient-specific summaries, guideline integration, and agent-driven workflows to support clinical decision making.
Multimodal RWD analytics platform (data catalog and Workspaces)
Cloud platform providing access to >8M de-identified records with linked genomic, clinical, and imaging data for cohort discovery, retrospective analyses, and hypothesis generation.
Comprehensive genomic profiling and liquid biopsy assays
Lab assays for tumor and matched normal DNA/RNA sequencing and cfDNA-based liquid biopsy to detect actionable variants, support therapy selection, and enable MRD/response monitoring.
Digital pathology imaging and AI model services
Centralized slide digitization, storage of whole‑slide images, and deployment of AI models to predict assay yield, MSI status, histologic features, and genomic correlates from H&E images.
Pharmacogenomic testing with patient-reported outcome tracking
Targeted PGx testing combined with a patient-facing symptom and response tracking application to inform psychiatric medication selection and follow-up.
Generative AI clinical assistant (EHR‑integrated)
A generative AI assistant that queries EHR data and institutional records to provide patient-specific summaries, guideline integration, and agent-driven workflows to support clinical decision making.
Multimodal RWD analytics platform (data catalog and Workspaces)
Cloud platform providing access to >8M de-identified records with linked genomic, clinical, and imaging data for cohort discovery, retrospective analyses, and hypothesis generation.
Comprehensive genomic profiling and liquid biopsy assays
Lab assays for tumor and matched normal DNA/RNA sequencing and cfDNA-based liquid biopsy to detect actionable variants, support therapy selection, and enable MRD/response monitoring.
Digital pathology imaging and AI model services
Centralized slide digitization, storage of whole‑slide images, and deployment of AI models to predict assay yield, MSI status, histologic features, and genomic correlates from H&E images.
Pharmacogenomic testing with patient-reported outcome tracking
Targeted PGx testing combined with a patient-facing symptom and response tracking application to inform psychiatric medication selection and follow-up.
Services
Engaged scientific and biostatistics teams perform scoped analyses of de-identified multimodal datasets to generate evidence supporting target discovery, indication prioritization, and trial feasibility.
Identification of relevant clinical trials for patients using combined clinical and molecular data, plus processes to rapidly open trials at network sites and nurse navigator support for enrollment.
Technical integration to connect ordering, result delivery, and AI clinical assistants into provider EHR systems to streamline ordering and return of genomic and algorithmic results.
Cloud-hosted workspaces for cohort discovery, exploratory analyses, and reproducible research with options to apply AI agents and transfer records for deeper investigation.
Engaged scientific and biostatistics teams perform scoped analyses of de-identified multimodal datasets to generate evidence supporting target discovery, indication prioritization, and trial feasibility.
Identification of relevant clinical trials for patients using combined clinical and molecular data, plus processes to rapidly open trials at network sites and nurse navigator support for enrollment.
Technical integration to connect ordering, result delivery, and AI clinical assistants into provider EHR systems to streamline ordering and return of genomic and algorithmic results.
Cloud-hosted workspaces for cohort discovery, exploratory analyses, and reproducible research with options to apply AI agents and transfer records for deeper investigation.
Expertise Areas
- Clinical trial matching and decentralized enrollment
- Comprehensive genomic profiling and liquid biopsy
- Digital pathology and image-based AI
- AI-driven clinical decision support and generative assistants
Key Technologies
- Next-generation sequencing (NGS)
- Whole-transcriptome sequencing
- Cell-free DNA (cfDNA) liquid biopsy
- Whole-slide imaging (digital pathology)